After a Hollywood tragedy, Trump’s reaction is stirring debate nationwide. But in California, where politics and pop culture often collide, the response is even sharper. On Monday morning, former ...

As 2025 reaches its end, President Donald Trump is approaching the conclusion of the first year of his second term in office. This comes as Trump made headlines with his response to the death of ...

Donald Trump is facing mounting backlash from both sides across the political spectrum following his social media post and comments about Rob Reiner's death. If you're wondering how it impacts his ...

Reddit is officially testing its own checkmark verification process with specific accounts, including celebrities, journalists and brands. In a recent release, the popular social forum-based platform ...

Porn has taken a hit in the UK in the wake of the introduction of compulsory age verification this year, according to communications regulator Ofcom. VPN usage more than doubled, while porn viewership ...

President Trump’s approval rating increased to 41 percent in a survey released Tuesday, buoyed by rising Republican support for his handling of the economy. The latest Reuters/Ipsos poll found Trump’s ...

The shift, while small, is notable after months of stability in President Trump’s approval rating. Note: Data as of 5 p.m. Eastern time on Dec. 4. The New York Times By Ruth Igielnik and Tyler Pager ...

Minnesota Gov. Tim Walz found himself back in the national spotlight after denouncing President Donald Trump for targeting him with a slur in a Thanksgiving social media post. Walz also accused Trump ...

A vulnerability in the ‘node-forge’ package, a popular JavaScript cryptography library, could be exploited to bypass signature verifications by crafting data that appears valid. The flaw is tracked as ...

It’s been just over a year since the FDA approved the first engineered cell therapy for the treatment of certain patients with advanced synovial sarcoma, a rare cancer that affects fewer than 1000 ...

President Trump’s approval hit a record low for his second term in the latest CNN/SSRS survey released Monday. The poll, conducted in late October, shows 37 percent of surveyed Americans approved of ...

Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly, unlocking a potential $1.5–$2.2B market and future label expansion. Palsonify offers superior efficacy and ...